Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorofeyev

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2018
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative ProctitisWolfgang Kruis, Viacheslav Neshta, Marina Pesegova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2023
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled TrialsAxel Dignass, Wolfgang Stremmel, Marek Horyński, et al.
Lancet (London, England)|April 2, 2019
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority studyByong Duk Ye, Marina Pesegova, Olga Alexeeva, et al.
Journal of Crohn'S & Colitis|June 16, 2022
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority TrialWolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2017
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrenceW Kruis, V Kardalinos, T Eisenbach, et al.
Annals of Hepatology|October 30, 2024
Global multi-societies endorsement of the MAFLD definitionMohamed Alboraie, Tawesak Tanwandee, Xiaoyuan Xu, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2018
Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative ProctitisWolfgang Kruis, Viacheslav Neshta, Marina Pesegova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2023
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled TrialsAxel Dignass, Wolfgang Stremmel, Marek Horyński, et al.
Lancet (London, England)|April 2, 2019
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority studyByong Duk Ye, Marina Pesegova, Olga Alexeeva, et al.
Journal of Crohn'S & Colitis|June 16, 2022
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority TrialWolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2017
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrenceW Kruis, V Kardalinos, T Eisenbach, et al.
Annals of Hepatology|October 30, 2024
Global multi-societies endorsement of the MAFLD definitionMohamed Alboraie, Tawesak Tanwandee, Xiaoyuan Xu, et al.
Pageof 4